VICORE PHARMA HOLDING AB ADR
VCRE · NASDAQ
更新於 2026-10-13 11:47:56
----
- 今日最高
- --
- 今日最低
- --
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $9.06
- 昨天收盤價
- $9.23
- 成交量
- 43.54K
- 市值
- $2.53B
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-1.91
昨天價格區間
$8.95$9.59
52週價格區間
$8.56$18.24
公司概況
- 板塊
- 醫療保健
- 行業
- 生物科技
- 子行業
- 生物科技
- 總部
- KORNHAMNSTORG 53, 斯德哥爾摩, 瑞典, 111 27
- 國家
- SE
- 上市日期
- 2015-12-10
- 財年截止
- 十二月
- 流通股數
- 281.53M
- CIK
- --
- 官方網址
- vicorepharma.com
Vicore Pharma Holding AB (publ) 是一間臨床階段製藥公司，於瑞典開發治療呼吸系統疾病的療法。該公司總部位於瑞典斯德哥爾摩。
財務指標
營業收入
2026-06-30
$2.21M
2026-03-31
$602K
2025-12-31
$419K
2025-06-30
$1.74M
營業支出
2026-06-30
$152.31M
2026-03-31
$124.44M
2025-12-31
$134.12M
2025-06-30
$112.91M
淨利潤
2026-06-30
-$142.84M
2026-03-31
-$108.61M
2025-12-31
-$137.1M
2025-06-30
-$115.36M
淨利潤率
2026-06-30
-6.45K%
2026-03-31
-18.04K%
2025-12-31
-32.72K%
2025-06-30
-6.6K%
每股收益
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-06-30
--
息稅折舊攤銷前利潤
2026-06-30
-$142.67M
2026-03-31
-$107.88M
2025-12-31
-$128.55M
2025-06-30
-$100.86M
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-06-30
--
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 |
|---|---|---|---|---|
| 營業收入 | $2.21M | $602K | $419K | $1.74M |
| 營業支出 | $152.31M | $124.44M | $134.12M | $112.91M |
| 淨利潤 | -$142.84M | -$108.61M | -$137.1M | -$115.36M |
| 淨利潤率 | -6.45K% | -18.04K% | -32.72K% | -6.6K% |
| 每股收益 | -- | -- | -- | -- |
| 息稅折舊攤銷前利潤 | -$142.67M | -$107.88M | -$128.55M | -$100.86M |
| 有效稅率 | -- | -- | -- | -- |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。